Evidence Hub

Laparoscopic Treatment of Severe Gastroesophageal Reflux Disease (GERD) in Schaaf-Yang Syndrome: First Report of Toupet Fundoplication

Kanna E, Batsari E, Lamprinou Z, Argyri I, Skondras I

Cureus, 2025

Abstract

Schaaf-Yang syndrome (SYS) is a rare genetic disorder marked by hypotonia, developmental delay, and feeding difficulties, including gastroesophageal reflux disease (GERD). We report the case of a 3-year-old boy with SYS who developed severe GERD and weight loss unresponsive to medical therapy. He underwent laparoscopic Toupet fundoplication with gastrostomy placement, resulting in complete symptom resolution and significant weight gain at one-year follow-up. To our knowledge, this is the first published report of Toupet fundoplication in a patient with SYS, highlighting its potential as a safe and effective surgical option for GERD management in this rare population.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free